
Study Period | 2019 - 2030 |
Market Size (2025) | USD 728.44 Million |
Market Size (2030) | USD 943.94 Million |
CAGR (2025 - 2030) | 5.32 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | High |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Intracardiac Echocardiography (ICE) Market Analysis
The Intracardiac Echocardiography Market size is estimated at USD 728.44 million in 2025, and is expected to reach USD 943.94 million by 2030, at a CAGR of 5.32% during the forecast period (2025-2030).
The COVID-19 outbreak had an unprecedented impact on the growth of the market. This outbreak resulted in the postponement and cancellation of various cardiac surgeries, affecting the demand for products in the Intracardiac Echocardiography devices market. The research article published by Europe PMC in July 2021 mentioned a 73% reduction in cardiac surgeries and a 74.3% reduction in catheterisation procedures from April to August 2020 in India. Such a reduction in cardiac procedures had a slight negative impact on the market's growth. However, with the relaxation of the lockdown, these postponed surgeries were carried out. COVID-19 has also impacted the cardiac health of people, increasing the demand for Cardiac Diagnostic Imaging such as Intracardiac Echocardiography. Hence, the studied market is expected to regain its growth over the coming five years.
The significant factors for the growth of the Intracardiac Echocardiography market include the growing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in interventional cardiology devices and Cardiac Imaging Software. Additionally, the burden of cardiac diseases is rising with the prevailing sedentary lifestyle of the population, which boosts the market's growth. According to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people lived with heart or circulatory disease in 2021. Such increasing prevalence of cardiovascular diseases led to the need for early diagnosis and imaging techniques such as Intracardiac Echocardiography, thus driving the market's growth.
Also, adopting Intracardiac Echocardiography catheters in surgical procedures is expected to contribute to the Intracardiac Echocardiography catheter market growth. For instance, in July 2021, the first minimally-invasive heart procedure using its real-time 3D Intracardiac Echocardiography catheter was conducted. Such adoption of Intracardiac Echocardiography procedures is expected to drive the Intracardiac Echocardiography market growth over the forecast period.
Factors such as the high burden of cardiovascular diseases, the rising geriatric population, and increasing usage of Intracardiac Echocardiography and other Cardiac Imaging techniques are expected to contribute to the Echocardiography market growth over the forecast period. However, factors such as the high cost, inadequate reimbursement, and lack of awareness in developing and underdeveloped countries are expected to restrain the market's growth over the forecast period.
Intracardiac Echocardiography (ICE) Market Trends
Electrophysiology is Expected to Hold a Significant Share in the Market Over the Forecast Period
Electrophysiology (EP) is a test performed to assess the heart's electrical system or activity and is used to diagnose abnormal heartbeats or arrhythmia. EP is performed by inserting catheters and wire electrodes, which measure electrical activity through blood vessels that enter the heart, often using Intracardiac Echocardiography catheters.
In electrophysiology procedures, Intracardiac Echocardiography (ICE), also known as Intracardiac Echo, allows the integration of real-time images with electroanatomic maps, which has a role in assessing arrhythmogenic substrate. It is particularly useful for mapping structures that are not visualised by fluoroscopies, utilizing a Cardiac Mapping System. Therefore, ICE is preferred over other diagnostic methods. With the increasing prevalence of arrhythmia in populations worldwide, the demand for electrophysiology procedures is expected to increase over the years, and the studied segment is expected to grow significantly.
According to the BMJ article published in August 2021, around 80% of the study participants diagnosed with atrial fibrillation in the United Kingdom were eligible for early rhythm control. Such prevalence of atrial fibrillation in the population eligible for early rhythm control is expected to drive the demand for electrophysiology procedures, thus contributing to the growth of the Intracardiac Echocardiography market.
With technological innovations, along with the rising adoption of imaging procedures for electrophysiology, the segment is further expected to grow over the forecast period. For instance, in July 2021, Mayo Clinic used a next-generation 4D ICE catheter in patients to guide heart procedures. The technology can also help physicians perform procedures without using general anesthesia on patients.
The increasing prevalence of various heart and circulatory disorders among the global population, and the rising demand for electrophysiology procedures are expected to contribute to the growth of the studied segment during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
With the rising focus on patient care and need, supported by the well-developed infrastructure and technologically advanced healthcare system, the increasing burden of cardiac diseases is expected to drive the growth of the Intracardiac Echocardiography market in the region.
Additionally, the rising geriatric population is also expected to drive the growth of the market in this region. For instance, the data published by Statistics Canada in August 2022 indicated that the population aged 70 to 74 years in Canada was 1,879,862, whereas the population aged 80 to 84 years was 878,672. Such a rise in the geriatric population who are prone to developing cardiovascular diseases is expected to drive the demand for minimally invasive cardiac procedures such as Intracardiac Echocardiography and Cardiac Imaging Systems, thereby contributing to the growth of the market in this region.
Furthermore, the rising product approvals and technologically advanced products are expected to boost the growth of the market during the forecast period. For instance, in April 2022, Franklin Mountain Medical received the Food and Drug Administration's clearance of its patented UltraNav Transseptal Catheter system for controlled access and delivery of cardiovascular catheters and guidewires to heart chambers. This visualization allows the delivery of catheters, including Intracardiac Echocardiography catheters for the intended treatment in the Intracardiac Echocardiography catheter market.
Similarly, in January 2021, Siemens Medical Solutions USA, Inc., received approval from the United States Food and Drug Administration for the ACUSON AcuNav volumetric intracardiac echocardiography catheter for legal marketing and usage, bolstering the Intracardiac Echocardiography devices market.
Thus, owing to the above-mentioned factors such as innovative product launches and high burden of cardiac disease is contributing to the growth of the Intracardiac Echocardiography market in the North America region over the forecast period.

Intracardiac Echocardiography (ICE) Industry Overview
The market is moderately competitive due to the presence of major market players at local and international levels. The major players in the Intracardiac Echocardiography devices market are Biomerics, Boston Scientific Corporation, Conavi Medical, Infraredx Inc., Koninklijke Philips NV, Siemens Healthcare GmbH, and Stryker Corporation, which hold a substantial market share.
Intracardiac Echocardiography (ICE) Market Leaders
-
Boston Scientific Corporation
-
Stryker Corporation
-
Conavi Medical
-
Koninklijke Philips N.V
-
Siemens Healthcare GmbH
- *Disclaimer: Major Players sorted in no particular order

Intracardiac Echocardiography (ICE) Market News
- September 2022: Baptist Health's Miami Cardiac and Vascular Institute used the VeriSight Pro, a real-time 3D intracardiac echocardiography catheter from Philips. The technology offers superior 2D and 3D live imaging guidance for a wide range of cardiac procedures in structural heart disease,
- March 2022: Seimens Healthineers launched the next-generation AcuNav Volume four-dimensional (4D) intracardiac echocardiography (ICE) catheter in the United States.
Intracardiac Echocardiography (ICE) Industry Segmentation
As per the report's scope, intracardiac echocardiography (ICE) refers to a unique imaging modality capable of providing high-resolution real-time visualization of cardiac structures, incessant monitoring of catheter location within the heart, and early detection of procedural complications, including pericardial effusion or thrombus formation.
The Intracardiac Echocardiography Market is segmented by application (Electrophysiology, Left Atrial Appendage Closure, Transcatheter Aortic Valve Implantation, MitraClip Implantation, and Mitral Valvuloplasty, Other Applications), end users (Hospitals, Diagnostic Centers, Other End Users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.
By Application | Electrophysiology | ||
Left Atrial Appendage Closure | |||
Transcatheter Aortic Valve Implantation | |||
MitraClip Implantation and Mitral Valvuloplasty | |||
Other Applications | |||
By End Users | Hospitals | ||
Diagnostic Centers | |||
Other End Users | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Intracardiac Echocardiography (ICE) Market Research FAQs
How big is the Intracardiac Echocardiography Market?
The Intracardiac Echocardiography Market size is expected to reach USD 728.44 million in 2025 and grow at a CAGR of 5.32% to reach USD 943.94 million by 2030.
What is the current Intracardiac Echocardiography Market size?
In 2025, the Intracardiac Echocardiography Market size is expected to reach USD 728.44 million.
Who are the key players in Intracardiac Echocardiography Market?
Boston Scientific Corporation, Stryker Corporation, Conavi Medical, Koninklijke Philips N.V and Siemens Healthcare GmbH are the major companies operating in the Intracardiac Echocardiography Market.
Which is the fastest growing region in Intracardiac Echocardiography Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Intracardiac Echocardiography Market?
In 2025, the North America accounts for the largest market share in Intracardiac Echocardiography Market.
What years does this Intracardiac Echocardiography Market cover, and what was the market size in 2024?
In 2024, the Intracardiac Echocardiography Market size was estimated at USD 689.69 million. The report covers the Intracardiac Echocardiography Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Intracardiac Echocardiography Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Intracardiac Echocardiography Industry Report
The Global Intracardiac Echocardiography Market is segmented by application, end users, and geography. The market report offers an in-depth industry analysis, providing valuable industry information and an industry overview. The report highlights key industry trends and industry statistics, which are essential for understanding the market dynamics.
The market segmentation includes applications such as Electrophysiology, Left Atrial Appendage Closure, Transcatheter Aortic Valve Implantation, MitraClip Implantation, and Mitral Valvuloplasty, among others. End users are categorized into Hospitals, Diagnostic Centers, and other end users. The geographic segmentation covers North America, Europe, Asia-Pacific, Middle East and Africa, and South America.
The market forecast outlines the expected market growth and industry outlook. The industry research includes a market review and market predictions, focusing on the market size and market value. The report provides insights into the market leaders and their strategies, contributing to the overall market growth.
The report example and report PDF are available for download, offering a comprehensive market analysis and market data. The market report is a valuable resource for research companies and industry stakeholders, providing a detailed market outlook and industry sales information. The report also includes a historical overview and a market forecast outlook, ensuring a thorough understanding of the market trends and market segmentation.